Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Journal of Gastroenterology and Hepatology|August 25, 2007
Role of mitochondria in non-alcoholic fatty liver diseaseDominique Pessayre
European Journal of Gastroenterology & Hepatology|October 19, 2004
Mitochondrial injury in steatohepatitisDominique Pessayre, Bernard Fromenty, Abdellah Mansouri
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 24, 2002
Nonalcoholic steatosis and steatohepatitis. V. Mitochondrial dysfunction in steatohepatitisDominique Pessayre, Abdellah Mansouri, Bernard Fromenty
Fundamental & Clinical Pharmacology|August 19, 2008
Drug-induced liver injury through mitochondrial dysfunction: mechanisms and detection during preclinical safety studiesGilles Labbe, Dominique Pessayre, Bernard Fromenty
Mitochondrion|January 13, 2006
Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent itKarima Begriche, Anissa Igoudjil, Dominique Pessayre, et al.
Handbook of Experimental Pharmacology|December 19, 2009
Mitochondrial involvement in drug-induced liver injuryDominique Pessayre, Abdellah Mansouri, Alain Berson, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|July 8, 2008
Steatohepatitis-inducing drugs trigger cytokeratin cross-links in hepatocytes. Possible contribution to Mallory-Denk body formationMarie-Anne Robin, Véronique Descatoire, Dominique Pessayre, et al.
Hepatology (Baltimore, Md.)|June 28, 2003
Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in micePhilippe Lettéron, Angela Sutton, Abdellah Mansouri, et al.
World Journal of Gastroenterology|May 24, 2006
Partial Beclin 1 silencing aggravates doxorubicin- and Fas-induced apoptosis in HepG2 cellsFanny Daniel, Agnès Legrand, Dominique Pessayre, et al.
Pageof 5